Aclarion Inc. Responds to Echo Lake Capital’s Acquisition Proposal
Aclarion Inc. (NASDAQ: ACON) issued a formal statement on 28 May 2026 addressing the unsolicited proposal from Echo Lake Capital, LLC. The letter, received earlier that day from Ephraim Fields, criticizes the current board’s performance, compensation structure, and governance practices while offering to acquire the company at a price of $4.00 per share in cash plus convertible voting rights (CVR) stock.
Echo Lake Capital’s Offer and Rationale
Echo Lake Capital’s proposal is anchored on a valuation that reflects the company’s liquid assets—approximately $17 million in cash, $12 million in deferred tax assets, and a debt‑free balance sheet—as well as a projected value of $6 million from a potential reverse takeover using Aclarion’s public shell. The firm’s analysis concludes that the current market price, which has fallen 99 % since the IPO, is deeply undervalued relative to these fundamentals.
The offer includes a cash component of $4.00 per share, which is above Aclarion’s intraday trading price of $3.12 but still well below the 52‑week high of $12.03. The CVR stock component is intended to provide an upside to shareholders should Aclarion’s business recover or be acquired at a higher valuation.
Board Governance and Compensation Concerns
Echo Lake Capital’s letter also raises serious concerns regarding board governance. The letter states that the board collectively owns only 25 shares—worth roughly $85—while the total compensation paid to board members exceeds $5.6 million, representing about 50 % of the company’s current equity market capitalization of $7.9 million. This disparity has eroded investor confidence and, according to the letter, has contributed to the dramatic decline in stock price.
The proposal further alleges that certain directors have failed to disclose significant personal liabilities, such as IRS tax liens, and have engaged in actions that may violate federal securities law. While these allegations are pending legal review, they underscore the urgency for Aclarion to reassess its board composition and remuneration policy.
Aclarion’s Position
In its response, Aclarion reaffirmed its commitment to its core mission: providing magnetic resonance spectroscopy (MRS) technology and proprietary biomarkers to optimize clinical treatments, coupled with artificial intelligence‑driven quality‑control tools. The company highlighted its strategic initiatives, including the development of a new AI‑enabled data‑flagging platform expected to reduce MRS study failures by 20 % in the next fiscal year.
The board emphasized that the current offer does not reflect the intrinsic value of Aclarion’s technology portfolio or the potential upside from upcoming regulatory approvals. Aclarion’s management team reiterated that a reverse takeover could create substantial value but only under conditions that ensure robust governance and alignment of director incentives with shareholder interests.
Forward‑Looking Outlook
Looking ahead, Aclarion is pursuing several growth levers that could materially increase shareholder value:
| Initiative | Expected Impact |
|---|---|
| Expansion of MRS‑based biomarker panels | 30 % revenue growth over next 12 months |
| Integration of AI quality‑control platform | 25 % reduction in study failure rates |
| Strategic partnerships with leading diagnostic firms | Access to $5 million in upfront licensing fees |
Given these developments, Aclarion’s board maintains that the company’s enterprise value will continue to rise, provided that governance reforms and capital allocation decisions align with long‑term shareholder interests. The board has scheduled a special meeting to review the unsolicited proposal, with a vote expected within the next two weeks.
The market reaction to the proposal remains mixed. While the offer’s cash component provides an immediate upside, investors are closely monitoring the board’s response to governance concerns and the potential for a reverse takeover to unlock hidden value.
This article is based exclusively on the information provided in the input and does not incorporate external data.
